IGXT - IntelGenx Technologies Corp.

QQQ $ 479.30 $ 2.47 (0.52 %)

DIA $ 386.46 $ -0.42 (-0.11 %)

SPY $ 542.65 $ 0.33 (0.06 %)

TLT $ 94.67 $ 0.79 (0.84 %)

GLD $ 215.76 $ 2.76 (1.3 %)

Previous Close

$ 0.167

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 0.09 - $ 0.22

Volume

37,230

Average Volume

Market Cap

29.17M

Beta (5Y Monthly)

$ 0.82

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-21-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-29-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-24-2022	12-31-2021	10-K
11	11-11-2021	09-30-2021	10-Q
12	08-04-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-25-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-Q
17	05-14-2020	03-31-2020	10-Q
18	03-26-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-08-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-22-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-29-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-28-2017	12-31-2016	10-K
31	11-10-2016	09-30-2016	10-Q
32	08-11-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-30-2016	12-31-2015	10-K
35	11-03-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-14-2015	03-31-2015	10-Q
38	03-31-2015	12-31-2014	10-K
39	11-12-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

psychedelics-headlines-mdma--coping-skills-in-ptsd-lsds-perceived-risks-knowledge-gaps-surveys--more

Psychedelics Headlines: MDMA & Coping Skil...
01/15/2024 18:38:32

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week ...

Intelgenx Technologies Q3 EPS $(0.01) Up F...
11/09/2023 21:32:54

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of ...

IntelGenx Announces Co-Development And Com...
11/06/2023 13:34:09

IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it and Tilray Brands ...

intelgenx-q2-2023-revenue-decline-67-operating-costs-rise-what-about-net-loss

IntelGenx Q2 2023: Revenue Decline 67%, Op...
08/15/2023 02:54:20

IntelGenx Technologies Corp. (TSX: IGX) (OTC: IGXT), a drug delivery company focused on the development and manufacturing of ph...

Intelgenx Technologies Q2 EPS $(0.02), Sam...
08/14/2023 20:32:49

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last y...

psyched-20m-research-fund-lsd-microdosing-for-cancer-meai-enters-clinical-stage-reform-update--more

Psyched: $20M Research Fund, LSD Microdosi...
05/15/2023 21:30:48

Researchers At Johns Hopkins Get $20M Fund Prompted By Longtime Psychedelics Scientist Johns Hopkins University academics rece...

fda-gives-nod-to-intelgenxs-migraine-solution-as-revenues-plunge-32-q1-results-report

FDA Gives Nod To IntelGenx's Migraine Solu...
05/11/2023 22:33:52

IntelGenx Technologies Corp. (OTC: IGXT) reported on Thursday a 32% decrease in total revenues for the first quarter of 2023, a...

Intelgenx Technologies Q1 EPS $(0.02), Sam...
05/11/2023 20:10:32

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.02) per share. This is unchanged from the same period last y...

psyched-canadas-case-for-psilocybin-access-and-microdose-trial-us-reform-update-battle-with-dea--more

Psyched: Canada's Case For Psilocybin Acce...
04/05/2023 13:57:15

Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsui...

intelgenxs-q4-and-full-year-2022-financials-on-the-cusp-of-rapid-growth

IntelGenx's Q4 And Full-Year 2022 Financia...
03/30/2023 19:31:40

Drug delivery company IntelGenx Technologies Corp. (OTCQB: IGXT)’s financial results for the three and twelve months ended Dece...

Intelgenx Technologies Q4 EPS $(0.01) Up F...
03/30/2023 05:09:51

Intelgenx Technologies (OTC:IGXT) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of ...

GH Research, Mind Medicine Among Top Psych...
01/31/2023 21:30:06

Intelgenx Technologies, Cybin Among Top Ps...
01/30/2023 21:30:07

Cybin, GH Research Among Top Psychedelic M...
01/27/2023 21:30:05

Psychedelic Stock Gainers And Losers From ...
01/26/2023 21:30:06

Biomind Labs, Intelgenx Technologies Among...
01/25/2023 21:30:06

Psychedelic Stock Gainers And Losers From ...
01/24/2023 21:30:06

Psychedelic Stock Gainers And Losers From ...
01/19/2023 21:30:06

GH Research, Cybin Among Top Psychedelic M...
01/16/2023 21:30:05

Psychedelic Stock Gainers And Losers From ...
01/13/2023 21:30:06

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)

07/01/2024 Equinix, Inc. (EQIX)

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)

IGXTIntelGenx Technologies Corp.

OTC intelgenx.com

$ -0.01 (-3.75 %)